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ABS TRACT
Industrialized society currently faces a wide range of non-infectious, immune-related pandemics.
These pandemics include a variety of autoimmune, inflammatory and allergic diseases that are often
associated with common environmental triggers and with genetic predisposition, but that do not occur
in developing societies. In this review, we briefly present the idea that these pandemics are due to
a limited number of evolutionary mismatches, the most damaging being ‘biome depletion’. This par-
ticular mismatch involves the loss of species from the ecosystem of the human body, the human
biome, many of which have traditionally been classified as parasites, although some may actually
be commensal or even mutualistic. This view, evolved from the ‘hygiene hypothesis’, encompasses a
broad ecological and evolutionary perspective that considers host-symbiont relations as plastic,
changing through ecological space and evolutionary time. Fortunately, this perspective provides a
blueprint, termed ‘biome reconstitution’, for disease treatment and especially for disease prevention.
Biome reconstitution includes the controlled and population-wide reintroduction (i.e. domestication)
of selected species that have been all but eradicated from the human biome in industrialized society
and holds great promise for the elimination of pandemics of allergic, inflammatory and autoimmune
diseases.
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DIAGNOSIS: PANDEMICS OF IMMUNE-RELATED DISEASE IN
INDUSTRIALIZED CULTURE
Despite an ever increasing understanding of the
human immune system, the field of immunology
faces staggering rates of allergic, autoimmune and
inflammatory diseases in industrialized societies [1,
2]. Diseases such as hay fever and food allergies,
which were not described prior to 1800 and which
are not found in today’s developing societies [3], are
now commonplace in the USA, the UK and in other
industrialized countries. With as much as 40% of the
US population suffering from allergic disorders [4,
5], and another 2–8% facing autoimmune condi-
tions [6], modern medicine has thus far failed to
contain the onslaught of non-infectious, immune-
related pandemics. This onslaught has contributed
to a rate of chronic illness in children that
approaches 50% [7] and may also be associated with
a variety of cognitive disorders [8, 9] including aut-
ism [10, 11] and, as discussed below, schizophrenia.
Despite this abysmal diagnosis, evolutionary biol-
ogy and anthropology have provided critical infor-
mation exposing a cause and subsequently a
solution for these pandemics of disease. It is the
purpose of this review to describe the evolutionary
biology underlying this cause and to examine a view
enlightened by evolutionary biology regarding a pos-
sible solution to the problem.
EVOLUTIONARY MISMATCH AS THE
UNDERLYING CAUSE OF PANDEMICS
OF IMMUNE-RELATED DISEASE
Based on epidemiologic studies, cleanliness
associated with modern sanitation was identified
as the factor responsible for allergic diseases>20
years ago [12]. This idea, labeled the ‘hygiene hypoth-
esis’, has been revised to the point that the term
hygiene hypothesis is a complete misnomer and
generally misleading [13, 14]. ‘Hygiene’, as the aver-
age industrialized citizen envisions hygiene (e.g.
dust under the bed or mold in the refrigerator), is
not involved [13, 15] in what is now a theoretical
framework, not a hypothesis, which explains a wide
range of non-infectious, immune-related diseases of
industrialized society. This current model, referred
to as ‘old friends’ [13] or ‘biome depletion’ [15],
encompasses studies from the fields of evolutionary
biology, anthropology, immunology, clinical re-
search, basic medical research, parasitology, ecol-
ogy and immunology. This model points to widely
appreciated attributes of industrialized society
as the causative factors underlying pandemics of
immune-related disease.
The primary factor associated with allergic and
autoimmune disease is apparently loss of species
diversity from the ecosystem of the human body,
the human biome. Species depleted or even
eliminated from the human biome include a wide
range of pathogens, commensals and mutualists
whose reproductive cycle is greatly diminished or
even eliminated by modern sanitation, water treat-
ment and medical practices [16–18]. Importantly,
the human biome, as with other biomes, not only
includes species that are permanent residents of
the ecosystem but also species that interact transi-
ently with the ecosystem [19]. The absence of species
from the human biome leaves the immune system
in a hypersensitive state that, when combined with
environmental triggers and genetic predisposition,
leads to allergic and autoimmune disease. The wide
range of evidence pointing incontrovertibly at this
conclusion (reviewed extensively by several authors
[8, 15–18, 20–22]) is summarized in Box 1. At the
same time, other factors that also contribute to both
allergic and autoimmune disease have been
identified. For example, deprivation from sunlight
as a result of indoor working environments has led
to widespread vitamin D deficiency and conse-
quently an increase in immune disease [23–26].
Other examples of factors associated with allergic
and autoimmune disease are deprivation from
mother’s milk [23, 25–29] and unrequited psycho-
logical stress [30–35]. Although it remains unknown
whether psychological stress is increased in
industrialized society, the other factors cited
above are directly attributable to the culture of
industrialized society. Fortunately, just as vitamin
D deficiency can be compensated for by supple-
ments, so can biome depletion be readily avoided
without abandonment of modern sanitation and
medicine that are necessary to avoid pandemics of
various infectious diseases [15, 21].
It is now well demonstrated if not widely
appreciated that an extensive list of allergic and
autoimmune diseases can be attributed to biome
depletion in conjunction with other consequences
of industrialized society such as vitamin D defi-
ciency. However, the list of diseases that is
associated with biome depletion is potentially much
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larger than previously thought (Table 1). Any dis-
ease that is associated with an immune response,
generally inflammatory in nature, not associated
with a genetic mutation, and lacks any apparent
adaptive function, is suspect. Such diseases known
to be present in industrialized but not developing
societies are very highly suspect. High on the list of
suspects are cognitive disorders that include
autism [10, 11, 51]. Although autism is clearly a
developmental disorder that may or may not be
associated with ongoing aberrant immune reactiv-
ity, a number of factors point toward neuroinflam-
matory reactions as the factor which derailed the
normal developmental process in most cases [10,
11, 52]. As described in Box 2, a wide range of cog-
nitive disorders other than autism, including
schizophrenia and migraine headaches, are
associated with inflammation and may possibly
be related to biome depletion. Given the potential
impact of the burden of immune-related cognitive
dysfunction in industrialized society, it is imperative
that the possible role of biome depletion in inflam-
mation-associated cognitive dysfunction be
investigated thoroughly. Adding urgency to this
mandate is the recognition that these neuro-
inflammatory-related diseases may be unavoidable
unless steps are taken to alleviate the hypersensi-
tive nature of the immune system in industrialized
society. Further, while prevention is much more
readily achieved than a cure for many allergic and
autoimmune diseases [53], prevention may be the
only effective option for cognitive problems
associated with neurodevelopment. Once the com-
plex milieu of biome depletion, genetics and other
environmental factors have come together to induce
neurodevelopmental disorders, it may be difficult if
not impossible in many cases to restore health.
Thus, biome reconstitution rather than treatment
box 1 . factors pointing at the importance of biome deplet ion in
the pathogenesis of allergic and autoimmune disease
. Clinical observations: Accidental helminth colonization halts the progression of multiple sclerosis [36].
. Clinical trials: Exposure to a porcine helminth, T. suis, effectively treats some patients with inflammatory bowel disease
previously untreatable with modern pharmaceuticals [37].
. Biomedical Research: Helminths effectively avert or treat experimentally induced colitis, experimentally induced allergy
and type 1 diabetes in rodent hosts [18, 91, 38–43].
. Immunology: (i) Helminth colonization enhances the production of regulatory elements [38, 44] that are known to
reduce the propensity for allergic and autoimmune disease. (ii) Helminths are known to produce a wide range of
molecules that tune down the immune system, thus decreasing the propensity for allergic and autoimmune disease
[45]. (iii) Studies of both human [46] and rodent [47, 48, 49, 50] immune systems in individuals with a normal (not
modified by modern technology and medicine) biome show an immune system with profoundly different regulation and
a hyporesponsive posture compared with immune systems from biome-depleted individuals.
. Evolutionary biology: Mammalian coevolution with helminths and other species (e.g. protozoans) have resulted in
‘adjustments’ in our immune function [43] so that effective immune function is dependent on the presence of a normal
biome (see text).
. Ecology: As with any ecosystem, profound changes in some aspects of the human biome are expected to have ram-
ifications for many or even all other components of the biome [15].
. Epidemiology: The introduction of effective water treatment facilities and sewage handling systems, in combination with
lingering effects of a normal biome on the immune system over decades or even generations (epigenetic effects) have
created a condition in which allergic and autoimmune disease are still on the rise, but only in industrialized parts of the
world.
. Lack of alternative explanations: Changes in breastfeeding practices, vitamin D levels and potentially psychological stress
doubtless play a role in the incidence of allergic and autoimmune disease in industrialized society. However, these factors
alone do not account for the widespread pandemics of allergic and autoimmune disease and, other than biome reconsti-
tution, no other explanations are presently under consideration. Although this factor is not direct evidence for the role of
biome depletion, it does underline the urgency of moving research forward at the fastest possible pace.
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of disease is mandated most strongly for prevention
of pandemics of inflammation-associated neuro-
developmental disorders.
The identification of biome depletion as the cause
for pandemics of immune disease carries with it a
solution: biome reconstitution. Although the extent
to which biome reconstitution can reverse disease
remains unknown at present, biome reconstitution
is hypothetically a readily available means of
preventing disease associated with biome depletion.
The overall goal underlying biome reconstitution is
to reconstitute and maintain the biome for the pre-
vention of disease rather than wait until treatment of
disease is necessary. With this in mind, biome re-
constitution is distinct from specific therapies
aimed at treating disease, just as regular physical
exercise is distinct from physical therapy aimed at
rehabilitating a sports injury. Biome reconstitution
Table 1. Some diseases associated or potentially associated with biome depletion
Disease Confirmed
in humansa
Supported
by animal
models
Industrializedb Role of
immunity
Role of
gender
Referencesc
Confirmed or very highly probable
Asthma 3 3 3 3 [3]
Food allergies 3 3 3 3 [54]
Hay fever or rhinitus 3 3 3 3 [12]
Multiple sclerosis 3 3 3 3 3 [55]
Eczema (some common types) 3 3 3 3 [56, 57]
Lupus 3 3 3 3 [6, 58]
Type 1 diabetes 3 3 3 3 [59–61]
Inflammatory bowel disease 3 3 3 3 3 [37]
Very probable based on role of immunity and other factors
Appendicitis 3 3 3 [3]
Graves’ disease 3 3 3 [6]
Eczema (some non-allergic types) 3 3 3 [57]
Non-tropical sprue (celiac disease
or gluten enteropathy)
3 3 3 [62]
Migraine headaches 3 3 3 [63]
Autism associated with
autoantibodies
Contested 3 3 [11, 51]
Heart disease (in part) 3 3 3 [64]
Hives (urticaria) 3 3 3 [65]
Schizophrenia 3 3 3 [52, 66, 67]
Dandruff 3 3 3 [68]
Suspect based on some aspects of the disease
Chronic fatigue syndrome Not known 3 3 [69]
All autism Contested Contested 3 [11]
Potential contributions to a range of neurological disorders
associated with attention deficiency, bipolar behavior,
anxiety, obsessive compulsiveness and depression
Additional
studies
needed
When
known
Usually [8, 70–72]
Contribution to inflammation
associated with injury
Unknown 3 Unknown [73]
Psoriatic arthritis Unknown 3 No [74]
aConfirmed in the sense that addition of helminths either reverses disease or halts the progression of disease. bAssociated with industrialized society
more so than hunter–gatherer or traditional agrarian societies, i.e. the epidemiology is consistent with biome depletion. cWhen applicable, the literature
cited refers to papers that connect specific diseases with biome depletion. In other cases, the literature cited refers to the epidemiology of disease.
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and maintenance should be considered an import-
ant aspect of healthy living, on par with a proper diet,
adequate exercise and sufficient rest. Nevertheless,
biome reconstitution is certainly appropriate for
biome-depleted individuals with allergic, autoim-
mune or other inflammatory-mediated diseases, so
some overlap with therapies such as helminth ther-
apy or microbiome transplants is expected.
BIOME RECONSTITUTION TO
COMPENSATE FOR EVOLUTIONARY
MISMATCH: THE MICROBIOME
Several components of the biome are important in
terms of clinical practice and reconstitution/main-
tenance. First, the microbiome, a subset of the
biome comprised of the microorganisms of the
biome, is often profoundly altered in industrialized
society, rendered both abnormal and unstable by
culture-specific practices. This alteration can hap-
pen initially as a result of extremely hygienic labor
and delivery practices [85–87] (e.g. delivery by
Caesarean section and/or cleaning of the baby with
detergent after birth) or if a newborn’s mother has an
altered microbiome. Subsequently, the microbiome
can be profoundly altered by substituting infant for-
mulas for breast milk [86, 88–91]. Later in life, broad
spectrum antibiotics commonly used in medical
practice pose a substantial risk. Further, exposure
to saprophytic bacteria is greatly diminished or even
lost altogether by some individuals in industrialized
society. These bacteria, commonly found in soil, are
still present in the environment, but cultural factors
diminish or eliminate their contact with humans
[16–18]. For example, prior to the widespread use
of water treatment facilities, saprophytic bacteria
would have been very common in virtually all
drinking water and in the food supply [18]. The
box 2 . cognit ive dysfunction as a result of biome deplet ion?
. Autism: Becker, in 2007, was the first to point out that genetic, epidemiologic and other factors point toward autism as
being associated with what is now known as biome depletion [10]. Data supporting this idea have continued to emerge
[51, 52], painting a picture of autism as a disease that has biome depletion at its roots, despite vast complexity and
variations in its pathological features. Although the epidemiology of autism remains a matter of contention, the strong
propensity for hyperimmune reactivity in industrialized society [1, 3] and the well-established effects of inflammation on
cognitive development [51] provide a rational and persuasive explanation for pandemics of autism in the absence of any
other explanation. In this model, the effects of biome depletion interact with various genetic and environmental factors,
leading to autism.
. Schizophrenia: Like autism, schizophrenia is characterized by profound cognitive dysfunction and is potentially linked to
biome depletion. The association of schizophrenia with inflammation [52, 67] points toward biome depletion, as does
the apparent association of schizophrenia with industrialized society [66, 75]. Schizophrenia and autism share familial
links [76], and the prevalence of schizophrenia in industrialized countries is approximately 1 in 100 [75], similar to that
of autism. Further, schizophrenia, like autism, is associated with infectious events during development [67] and other
risk factors associated with autism [77].
. Bipolar disorder and migraine headaches: Their association with inflammation [63, 72] and their links with autism and
schizophrenia [70, 76, 78] suggest that both bipolar disorder and migraine headaches might be yet another result of
biome depletion.
. Depression and anxiety disorders: Both depression and anxiety disorders share two hallmarks of biome depletion-
associated disease: they are associated with inflammation [14, 79–82] and affect wide swaths of the population in
industrialized society.
. Unanswered questions: It has been argued that the increased diagnosis of at least some diseases associated with
cognitive dysfunction and inflammation might reflect, at least in part, changing medical practice rather than an actual
change in the incidence of disease [83, 84]. On the other hand, it is difficult to understand how a disease could be
associated with inflammation, and yet not be epidemic in a society known to impose inflammation-associated diseases
on the population. Unfortunately, given difficulties associated with comparing mental status over large gaps in time and
culture, it seems likely that conclusive and unequivocal answers will bring an end to this debate only after biome
reconstitution in humans is carried out.
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effects of depleting saprophytic bacteria from the
human biome are unknown, although the bacteria
modulate the immune system, having potent effects
that can modulate emotional behavior and mood
[92]. Graham Rook, with convincing, extensive and
mounting evidence, has pioneered the view that that
exposure to these bacteria should be an important
element of biome reconstitution [17].
Constitution, reconstitution (if needed) and
maintenance of the microbiome as a whole are un-
doubtedly vitally important for biome normalcy.
Practices that alter the microbiome such as treat-
ment with antibiotics or the use of infant formulas
as a substitute for breastmilk are associated with
both allergic and autoimmune disease [93–98].
Some progress is being made toward maintaining
the microbiome. Advances in implementing
microbiome-friendly birthing practices are being
made in some parts of the world, and most medical
centers are strongly encouraging breast feeding,
with some success. At the same time, colonic
microbiome transplants have proven extremely suc-
cessful at reconstituting the colonic flora of people
whose colonic microbiomes have become dramatic-
ally altered following treatment with antibiotics.
In particular, recurrent Clostridium difficile colitis,
a debilitating disease associated with alteration of
the microbiome following use of broad spectrum
antibiotics, has proven much more treatable with
colonic microbiome transplants than with other
available treatments [99–104]. Despite striking and
undisputed successes with colonic microbiome
transplants, use of the transplants is not yet wide-
spread [99], and the reconstitution of other
microbiome compartments, including that of the
skin [105], the sinuses [106] and the vagina [107,
108], has been given no attention whatsoever in
clinical practice. Further, establishment of the
microbiome in newborns is seldom a priority in clin-
ical practice. Thus, (i) current knowledge regarding
reconstitution of the microbiome is not being widely
utilized, (ii) exciting findings reported in the litera-
ture have seldom been translated into wide-spread
practice and (iii) many potential therapeutic
approaches remain unexplored. With this in mind,
future efforts at biome reconstitution should
consider risk factors associated with microbiome
alteration (e.g. birth by Caesarean section, use of
antibiotics or lack of exposure to saprophytic
bacteria) and take appropriate preventative meas-
ures to avoid the consequences of microbiome
alteration.
BIOME RECONSTITUTION TO
COMPENSATE FOR EVOLUTIONARY
MISMATCH: EUKARYOTIC ORGANISMS
Although the microbiome is sometimes destabilized
or altered in industrialized cultures, other compo-
nents of the biome have fared far, far worse. A wide
range of eukaryotic pathogens, parasites, com-
mensals and (potential—see below) mutualists that
were once ubiquitous in humanity have been all but
annihilated in industrialized populations. These or-
ganisms, which include a variety of pathogenic
protozoans and helminths, cannot survive in the
face of modern sanitation and water treatment
facilities. Several lines of evidence indicate that it
is these organisms that are most profoundly missed
by industrialized immune systems (Box 1). To recon-
stitute this component of the biome, eukaryotic
organisms that are best suited for preventing dis-
ease without causing adverse side effects must be
selected or generated, starting from the wide range
of species that the human immune system has
coexisted with during its evolutionary history. This
approach equates to domesticating a very limited
number of species for the purpose of human health
(Fig. 1). This idea has been described previously [15,
21] and involves selecting species, most likely
helminths, which have properties that make them
suitable for biome reconstitution as follows:
(1) Should have negligible adverse side effects.
(2) Should not reproduce under conditions of
industrialized society.
(3) A single exposure or at most a very limited
number of exposures should have effects that
last for decades, as with vaccines. This condi-
tion probably dictates that long-term coloniza-
tion needs to be established. The importance
of this condition for public health cannot be
underestimated given that a significant
percentage of the population in industrialized
society is underserved by the medical commu-
nity, having limited contact with medical pro-
fessionals for the prevention and treatment of
disease [109–111].
(4) The colonization should be readily reversible,
if need be.
(5) It must be cost-effective. Treating the entire
industrialized population will dictate that,
as with vaccines, the cost of treatment for
a single individual must be relatively
insignificant.
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Fortunately, colonization (not ‘infection’, which
designates a pathogenic process) with helminths
looks like a reasonable choice as a starting point
for treating patients, although no one helminth ne-
cessarily fits all of the ‘ideal’ criteria described above
(Box 3). The porcine whipworm (Trichuris suis: defini-
tive host = Sus scrofa) has undergone the most
testing in humans [112] and has proven useful in
treating some inflammatory diseases. However, this
species is clearly unsuitable for biome reconstitu-
tion, which is aimed primarily at ‘preventing’ (as
opposed to treating) disease in the human popula-
tion. The critical limitation inherent in the porcine
whipworm is the fact that the porcine whipworm
does not effectively colonize humans, and any
immunomodulatory effect is temporary. Thus, ex-
posure must be repeated on a regular basis, as often
as once every 2 weeks. Other limitations of the por-
cine whipworm include the fact that the organisms
must be isolated from pigs, which are expensive to
maintain in pathogen-free conditions. With this in
mind, reconstituting the biome of a majority of the
human population with this species is not feasible.
Although use of the porcine whipworm in its nat-
urally occurring form is inadequate for biome recon-
stitution, other approaches (Fig. 1 and Box 3) hold
great promise for the future of clinical immunology.
The first step is to find the most useful naturally
box 3 . potential helminths for biome reconstitution
. The ‘rat tapeworm’ (Hymenolepis diminuta: definitive host =Rattus norvegicus, with H. sapiens as a potential substitute;
intermediate hosts = arthropods) has no adverse side effects in humans [114, 115]. The view that this helminth might
help treat autoimmune disease is supported by the observation that exposure to this helminth elicits an increase in
eosinophil counts [115], which is a hallmark of helminth colonization that abrogates multiple sclerosis in humans [55].
The rat tapeworm has the advantage that it can be cultivated in clean laboratory rodents and in grain beetles, com-
ponents of which are already (unavoidably and harmlessly) present in the human food supply [116]. The disadvantage
of the rat tapeworm is that it may require repeated exposures to have a long-term beneficial effect. Further, the rat
tapeworm may not colonize immunocompetent adult humans well [115], and the lifespan of the helminth is limited to a
few years. Thus, long-term treatment with a single dose of the rat tapeworm seems unlikely.
. Potentially accommodating the need for long-term colonization is the ‘bovine tapeworm’ (Taenia saginata; definitive
host =H. sapiens, intermediate host =Bos taurus), which can readily survive in humans for >20 years. Although the
bovine tapeworm is considered a commensal (non-detrimental) in humans [117], it produces egg sacks (proglottids)
that are motile and thus present a potential psychological barrier to their use. Thus, it is expected that modification of
the bovine tapeworm, either by genetic manipulation or by selection of naturally occurring variants, so that eggs or non-
motile egg sacs rather than motile egg sacs are released from the host, will greatly increase the potential utility of the
bovine tapeworm in humans.
. Another species already undergoing clinical trials [118, 119] is the ‘human hookworm’ (Necator americanus;
host =H. sapiens, with incubation in soil required between hosts for completion of its life cycle). Like the rat tapeworm,
this organism has a limited lifespan and thus may require repeated exposure.
Figure 1. Selection and cultivation of a limited number of
candidates for ‘biome reconstitution’ from a very broad array
of organisms which colonize humans. A wide range of organ-
isms, including those that cause dangerous infectious dis-
eases, could potentially ‘stabilize’ the immune system so
that it does not cause allergic and autoimmune disease.
However, for biome reconstitution, only those organisms
are of interest for which (a) the rate of colonization can be
easily controlled, and (b) no severe adverse side effects
are observed at levels that stabilize the immune system.
Subsequent to this initial selection process, selective
breeding, genetic manipulation or other approaches (e.g. ster-
ilization to prevent reproduction or technological innovations
to facilitate shipping and storage) may serve as a second
round of the domestication process to obtain more optimal
domestic species. In this manner, the proposed domestica-
tion of helminths parallels the apparent pathway by which
canines were domesticated by humans [113]
Biome reconstitution for immune disorders Parker and Ollerton | 95
 at U
niversityof N
ortham
pton on M
ay 22, 2013
http://em
ph.oxfordjournals.org/
D
ow
nloaded from
 
occurring organisms in terms of effective treatment/
prevention of disease, lack of adverse side effects,
ability to control colonization rate and feasibility of
treatment. A second phase of biome reconstitution
might utilize modified organisms. For example,
studies directed at understanding the longevity of
parasitic worms [120], now aimed at producing
drugs to eradicate the parasites, could, in addition,
conceivably be used in efforts to extend the longevity
of mutualistic helminths.
EVOLUTION OF OUR CONNECTION WITH
OUR COEVOLUTIONARY PARTNERS
A wide appreciation for the nature of the relationship
between humans and the helminths that they host is
potentially a critical factor in gaining acceptance
from the medical community and indeed the public
for biome reconstitution. Understanding this com-
plex relationship requires a broader comprehension
of the ecology and evolutionary biology of interspe-
cific relationships. Interactions between wholly un-
related species are a ubiquitous feature of the
Earth’s biodiversity, and all organisms interact with
individuals of other species for at least part (and
frequently for all) of their lifespans. The outcome
of these interactions can be assessed in terms of
the effect that it has on an organism’s Darwinian
fitness, i.e. its ability to reproduce and the quality
and quantity of its offspring.
Organismal biologists have traditionally cate-
gorized interactions between species in rather fixed
terms, i.e. species a parasitizes species b; species x
and y are mutualistic partners and so forth. This is
fine as a first approximation, but in many cases, the
nature of the interaction, defined by its effect on
Darwinian fitness, are not fixed but are context de-
pendent [121]. For example, almost 88% of the 350
000 species of flowering plants are biotically
pollinated and use bees, butterflies, birds and other
animals to disperse their pollen [122]. In most cir-
cumstances, this is a textbook example of a mutual-
istic relationship in which the pollinator gains a
reward (usually food in the form of nectar or pollen)
and the sexual reproduction of the plant is assured.
But not all individual flower-visiting animals carry
pollen, or are large enough to contact the sexual
parts of a flower, or behave in a manner that will
ensure that pollination takes place. In such circum-
stances, the relationship changes to a parasitic one
because, while the flower visitor obtains food, the
plant loses resources without being pollinated. In
another example, 80% of all land plants are thought
to have mycorrhizal relationships with fungi [123] in
which the fungus passes water and nutrients from
the soil to the plant’s roots, while the plant provides
photosynthetically derived carbohydrates to the fun-
gus. However, this mutualistic relationship can
change to a parasitic one under some circum-
stances, with either the plant or the fungus providing
no overall benefit to the partner [124].
The continuum between mutualistic and antagon-
istic interactions can be labile over evolutionary
time scales as well as across ecological contexts.
However, our understanding of how mutualism
evolves into parasitism or vice versa, for example,
is currently limited. Some patterns are evident from
comparisons between related taxa, but elucidating
the biological steps, and the selective pressures,
underlying the evolution of these changes is not
straightforward. One way to approach this is to
model how ‘cheating’ and ‘cooperative’ genotypes
fare when they interact with their host. Under differ-
ent scenarios, the host may evolve mechanisms that
accommodate the cooperator (for example, by
providing access to a resource) or apply sanctions
to the cheater (by withdrawing that resource) [125].
In the specific case of humans (or mammals more
broadly) and helminths, the transition from parasit-
ism to commensalism or mutualism may have
involved a two-sided accommodation. One can en-
visage a chain of events in which genotypes of hel-
minth species that have less of a negative impact on
their host’s health (and therefore fitness) are
tolerated in a commensal sense. Gradually this ac-
commodation by the host becomes a reliance as the
immune systems of some host genotypes evolve to
‘expect’ the presence of the helminths. Such an ‘ex-
pectation’ clearly involves the immune system gen-
etically adapting to the presence of the symbionts,
though the exact details are potentially vastly com-
plex and certainly poorly understood.
Individuals ofHomo sapiens are no different to any
other organisms on the planet with respect to their
interactions with other species. Some types of inter-
action are very rare, e.g. active predation by large
animals. Others are widespread but with variable
prevalence, such as parasitism by microorganisms
(infectious disease). However, relationships with
skin and gut colonizing microorganisms (which
are at least partly commensalistic or mutualistic)
are ubiquitous in all human populations [126–128].
With regard to the focus of this review, mutualisms
between humans and other species are of particular
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interest. It has been proposed that, as well as gut and
skin bacterial interactions, humans engage in mu-
tualisms with a wide range of organisms, whether we
are aware of it or not. This includes crop plants, food
animals and domesticated pets, while traditional
cultures have long engaged in cooperative relation-
ships with wild animals such as honeyguides and
dolphins [129, 130], and even urban societies benefit
from interactions with local wildlife (e.g. humans
and vultures in the Middle East [131]).
Mutualistic relationships between species have
been described as ‘biological barter’ in that the spe-
cies involved trade resources and/or services that
are easily available to one species, but in short sup-
ply for the other [132]. Resources that are traded are
hugely varied and include carbohydrates, inorganic
nutrients, water and complex organic and inorganic
chemicals. ‘Services’ are more restrictive in their
range; gamete and offspring distribution via pollin-
ation and seed dispersal are well known, but other
examples include physical defense of one organism
by another (for example, anemonefish and their sea
anemone hosts), cleaning relationships (for ex-
ample, between fish or birds and mammals) and
some forms of bioluminescence.
Where do human–helminth relationships sit
within the notion of biological barter and the con-
cept of biological interactions that fluctuate over
ecological space and evolutionary time? Helminths
are clearly obtaining nutrients and water from their
physical host, as well as physical defense from the
environment outside. So this relationship is based
partly on resources and partly on defense, provided
by the host. From the human host perspective, hel-
minths have traditionally been viewed as always
parasitic (e.g. [133]), and there is no doubt that
under certain circumstances, helminths can have a
negative effect on human health. However, in light of
the biome depletion view, the interaction between
helminths and humans needs to be recast as mu-
tualistic, at least under certain conditions. In this
view, the ‘assistance’ offered by the helminth in the
development of a more effective (less prone to dis-
ease) immune system by the human would be
categorized as a service.
BIOME RECONSTITUTION:
CONSIDERATIONS
As clinical work in this area proceeds to test the ideas
described above regarding the effects of biome de-
pletion and reconstitution on disease, several
factors should be kept in mind. First, because the
ecosystem of the human body has evolved with vast
complexity, it seems unlikely that pharmaceutical
interventions will ever prove successful in effectively
treating biome depletion-associated disease. Biome
reconstitution is intuitively the only available alter-
native if indeed biome depletion is at the root of the
problem. Second, because the prevalence of condi-
tions with high morbidity apparently associated with
biome depletion is extremely high, exhaustive and
systematic research is urgently needed. Third, be-
cause the effects of some pathologic immune reac-
tions may be irreversible and/or may occur early in
fetal development (e.g. autism), assessment of
prophylactic normalization of the human biome is
necessary.
Some concerns for patient safety might be raised
as widespread biome reconstitution is considered.
Indeed, we have pointed out several factors that
might be counterindications for biome reconstitu-
tion, including immunosuppression caused either
by immunodeficiency or by immunosuppressive
drugs [15]. In addition, many questions regarding
the implementation of biome reconstitution remain
to be addressed (Box 4). For example, it remains
unknown to what extent biome reconstitution will
affect universal medical issues such as aging, vac-
cine efficiency and the pathogenesis of common in-
fectious diseases such as the flu [15]. Thus, biome
reconstitution, at least initially, should be managed
by medical professionals. However, given (i) the vast
experience pointing toward the safety of various
components of the biome (e.g. certain helminths
and the microbiome), (ii) the safeguards that will
necessarily be put in place to prevent uncontrolled
spread of infectious species (see earlier discussion)
and (iii) the horrific consequences of biome deple-
tion on human health, it seems foolhardy to further
delay immediate efforts aimed at establishing biome
reconstitution.
The level of difficulty that might be encountered
when normalizing the biome is worth consideration.
Fortunately, data from studies in laboratory rodents
suggest that prevention of a wide range of allergic
and autoimmune diseases may be achieved using a
range of organisms [53]. Even more encouraging
was the observation that colonization with a variety
of helminths was sufficient to halt the progression of
multiple sclerosis in humans [36]. In other words, no
one particular helminth was necessary: the rules for
reconstitution are apparently flexible. Consistent
with this view, data from the analysis of immunity
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box 4 . unknown factors regarding biome reconstitution which
deserve immediate and thorough invest igat ion
These factors have been described previously [21] and will focus on the use of helminths. The answer to these questions
will be probably be affected by such variables as host age, pregnancy, disease state, gender, current state of the biome,
state of the patient’s maternal biome and other factors.
. Which helminths? The species or combination of species and the dose (quantity and frequency of administration) of
helminths that are safe and effective for treatment of disease must be determined.
. Which diseases? At present, it remains unknown which diseases can be cured or effectively treated with biome recon-
stitution, versus which can be prevented but not cured by biome reconstitution. In addition, it seems likely that some
diseases that respond to biome reconstitution may not be anticipated. That is, some positive effects of biome recon-
stitution may come as a surprise to the medical community.
. Prophylaxis? Although it is anticipated that prevention of disease with biome reconstitution will prove easier than
treatment, the requirements necessary to prevent disease will also need to be evaluated, especially for the purpose of
preventing neurodevelopmental disorders.
. Which patients? The risks versus the potential benefits for reconstituting the biome of patients who have medical
conditions (e.g. suppressed immune system, anemia and coagulopathy) that might make biome reconstitution more
risky need to be determined.
. Individualized medicine? Whether biome reconstitution can be individualized may deserve attention (i.e. can biome
reconstitution be tailored to the genotype of the patient?).
. Unexpected effects? The effect of biome reconstitution on human biology will need to be monitored carefully, since it
may have an impact on a wide array of medical issues. For example, biome reconstitution might alter the efficacy of
medical tools such as vaccines and immunosuppressive drugs, and might affect processes such as aging and resist-
ance to infectious disease.
Figure 2. A hypothetical ‘Biome Reconstitution and Maintenance Institute’, the necessary components of which are all readily available at any major medical
center today. The development of a biome reconstitution institute or center requires only reassignment of available components to new tasks. It is expected that
procedures similar or identical to those already established will be used to accredit clinical laboratories, evaluate experimental treatments and provide oversight for
animal use. This hypothetical diagram shows the inclusion of microbiome transplants (e.g. colonic microbiome transplants) as well as colonization with both
human-derived and animal-derived helminths as a part of a center. However, in practice, microbiome transplants may be relegated to a different area, the use of
helminths from more than one source may prove unnecessary, and other components of the biome (e.g. saprophytic bacteria) may also be utilized by the center for
biome reconstitution
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in wild rodents [47, 48] indicate that the ‘normal’
immune system, one free of the influences of mod-
ern medicine and water treatment technology, is
highly variable depending on the environment.
Thus, ‘normal’ immunity probably covers a very wide
range, again suggesting that the rules for biome re-
constitution are quite flexible. Thus, any one of a
wide range of organisms or combination of such
organisms might be adequate for biome reconstitu-
tion and the prevention of disease. Again, however,
efforts to treat or cure disease are expected to prove
more difficult than prevention [53], at least in some
cases.
Fortunately, the actual components of a ‘Biome
Reconstitution Center’ (Fig. 2) can readily be
assembled at any major medical center with re-
search capabilities. These components are in fact
already present and available at any major academic
medical center, although they typically do not work
together for patient treatment. These necessary
components include (i) the ability to screen donors,
either human or non-human as needed depending
on the organisms utilized for biome reconstitution,
(ii) animal housing facilities as needed depending
on the organisms utilized for biome reconstitution,
(iii) appropriate review boards to ensure patient
safety, (iv) clinical laboratories to safely purify the
organisms for biome reconstitution and (v) the ad-
ministrative and medical personnel to treat and
monitor patients.
The field of clinical immunology is arguably the
medical field which has the most to gain from an
appreciation for the evolution of H. sapiens, and par-
ticularly the coevolution of the multiple species
which comprise the human biome. Although the ef-
fects of altered diet and exercise in industrialized
culture are evident and well understood from an evo-
lutionary perspective, prevention of these effects is
mired in issues involving patient education, social-
ization and compliance. In contrast, the field of clin-
ical immunology can be energized and enabled in a
manner that treats patients effectively with biome
reconstitution to avoid allergic and autoimmune dis-
eases, just as patients are treated effectively with
vaccines to prevent infectious disease.
Some might argue that the widespread applica-
tion of biome reconstitution will be difficult to
achieve quickly. Current medical infrastructure is
largely focused on development of patent-protected
therapeutics controlled by companies with vast fi-
nancial investments [53] and is aimed at treatment
of individual diseases, not on prevention of wide
swaths of diseases [53]. Biome reconstitution, in
contrast, holds a promise for exposure of all individ-
uals to naturally occurring organisms or selected
variants of those organisms in a way that is required
for human health. Such exposure must be con-
sidered a fundamental human right worthy of gov-
ernment support rather than an option for
pharmaceutical development. This dichotomy and
the fact that paradigms in science and medicine
are slow to change [134] might suggest that biome
reconstitution is a dream for the distant future.
However, with the heavy burden of disease as a
driving force, a ‘tipping point’ might be quickly
reached after initial successes of pioneers in the
field [21]. This view points toward a bright and near
future for both biome reconstitution and clinical
immunology.
CONCLUSIONS
Evolutionary mismatches have left the typical im-
mune system of industrialized humans prone to a
wide range of allergic, autoimmune and inflamma-
tory disease. Primary among these mismatches is
the loss of helminths from the human biome. An
improved understanding of the helminth/host
relationship is likely important for clinicians and
the public alike to accept biome reconstitution,
or the reintroduction of mutualistic species into
the human biome. In this manner, medical practice
can accommodate the limitations of our genes as
imposed by our evolutionary history, which will lead
to dramatically improved public health and a revital-
ization of the field of clinical immunology.
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